|
|
|
|
Flu-like symptoms and injection site reactions are adverse effects of treatment with interferon Beta-1b in patients with MS. We compared gradual dose escalation, ibuprofen treatment, or their combination in an open-label study. The combin ation reduced the incidence of flu-like symptoms to rates comparable with the placebo group in the pivotal trial but increased the frequency of injection site reactions, albeit modestly and transiently. |
|